ArticleNeuro-oncology2022
Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma.
Sara Badodi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleNeuro-oncology2022
Sara Badodi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.